Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g


Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and 3 lots of Ceftriaxone for Injection, USP 2g, to the hospital/physician level. The products have been found to contain visual grey particulate matter in reconstituted vials. (US Food Recalls) More More

Similar stories

Lupin recalls 42 lots of antibiotic after contaminate found in vials - In-PharmaTechnologist.com

Lupin recalls 42 lots of antibiotic after contaminate found in vials  In-PharmaTechnologist.com

Lupin Pharmaceuticals voluntarily recalling lots of Ceftriaxone for Injection after rubber flecks were found in vials. The recall comes after Ceftriaxone for injection ...

Posted on 14 January 2019 | 3:00 am | Google News

Lupin Pharmaceuticals, Inc. Recalls Ceftriaxone for Injection - Pharmaceutical Technology Magazine

Lupin Pharmaceuticals, Inc. Recalls Ceftriaxone for Injection  Pharmaceutical Technology Magazine

FDA announced on January 5, 2019 that Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg; 10 lots of Ceftriaxone ...

Posted on 7 January 2019 | 3:00 am | Google News

Lupin Pharma issues voluntary recall of Ceftriaxone for Injection - BSI bureau

Lupin Pharma issues voluntary recall of Ceftriaxone for Injection  BSI bureau

Ceftriaxone for Injection, USP, is used as a sterile, semi-synthetic, broad-spectrum cephalosporin antibiotic for intravenous or intramuscular administration.

Posted on 7 January 2019 | 3:00 am | Google News

Lupin Recalls 42 Lots of Ceftriaxone for Injection - Pharmacy Times

Lupin Recalls 42 Lots of Ceftriaxone for Injection  Pharmacy Times

Lupin Pharmaceuticals, Inc. has voluntarily recalled 42 of lots of Ceftriaxone for Injection, USP products at the hospital/physician level. These products were ...

Posted on 7 January 2019 | 3:00 am | Google News

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g - Business Wire

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g  Business Wire

BALTIMORE--(BUSINESS WIRE)--Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for ...

Posted on 5 January 2019 | 3:00 am | Google News

Lupin and AbbVie Announce Partnership to Develop and Commercialize Novel Oncology Drug to Treat Hematological Cancers - Business Wire

Lupin and AbbVie Announce Partnership to Develop and Commercialize Novel Oncology Drug to Treat Hematological Cancers  Business Wire

Lupin today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.

Posted on 24 December 2018 | 3:00 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info